Jaguar Health, Inc. has announced plans to offer up to $75 million in shares of its common stock through a newly filed prospectus supplement. This move is part of the company's ongoing strategy to enhance its financial position and support the development of its proprietary pharmaceutical products.

The filing, dated November 9, 2026, details the company's agreement with Ladenburg Thalmann & Co. Inc. to act as the sole sales agent for this offering. Jaguar Health is focused on developing novel prescription drugs derived from plants, particularly for patients with complicated gastrointestinal diseases.

Background

Founded in 2013 and based in San Francisco, California, Jaguar Health operates under the Standard Industrial Classification (SIC) code 2834, which pertains to Pharmaceutical Preparations. The company trades on the Nasdaq under the ticker symbol JAGX. Recent filings include a registration statement on Form S-3 and a base prospectus dated November 5, 2026.

What the Filing Says

The prospectus supplement outlines the terms of the At The Market (ATM) Offering Agreement, which allows Jaguar to sell shares of its common stock from time to time. The company has previously sold approximately $71.8 million under the ATM Agreement and is now looking to increase that amount. The filing states, "We may offer and sell shares of our common stock from time to time through Ladenburg." Additionally, it mentions that sales may be made at market prices prevailing at the time of sale.

Impact

This offering may significantly affect the company's ability to fund its operations and expand its product pipeline. Investors and stakeholders in the pharmaceutical preparations industry will be watching closely to see how this funding impacts Jaguar's growth and market strategy. The move may also influence competitors in the sector as they respond to Jaguar's enhanced financial capabilities.

What's Next

The filing does not specify what happens next, but it indicates that sales of common stock will occur as deemed appropriate under the terms of the ATM Agreement.